Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer (FANG Ovarian)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01309230
Recruitment Status : Active, not recruiting
First Posted : March 7, 2011
Last Update Posted : July 16, 2018
Information provided by (Responsible Party):
Gradalis, Inc.